Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2

Eriko Fujimoto1, Haruna Satoh, Etsuko Negishi

  • 1Faculty of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Insights

Connexin 32 (Cx32) suppresses renal cell carcinoma (RCC) growth by inhibiting cell-cycle progression and Her-2 activation. Restoring Cx32 in RCC cells promotes contact inhibition and reduces tumor cell proliferation.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Biology

Background:

  • Connexin (Cx) genes exhibit cell-specific negative growth effects on tumor cells.
  • Cx32 is downregulated in human renal cell carcinoma (RCC) and its progenitor cells.
  • The specific role of Cx32 in RCC growth control is not fully understood.

Purpose of the Study:

  • To investigate the growth-controlling function of Cx32 in human RCC cells.
  • To determine the molecular mechanisms underlying Cx32-mediated growth inhibition in RCC.

Main Methods:

  • Stable expression of Cx32 genes in Caki-2 RCC cells.
  • Assessment of cell growth control, including contact inhibition and anchorage-independent growth.
  • Cell-cycle analysis to determine the effect on G1 to S phase transition.
  • Investigation of the role of Her-2 activation using short interfering RNA (siRNA).

Main Results:

  • Cx32 expression induced contact inhibition and reduced anchorage-independent growth in Caki-2 cells.
  • Cx32 inhibited cell-cycle transition from G1 to S phase at high cell density.
  • Cx32-mediated growth control was linked to the suppression of Her-2 activation.
  • Suppression of Cx32 by siRNA led to Her-2 activation.

Conclusions:

  • Cx32 exerts negative growth control on Caki-2 RCC cells.
  • This growth inhibition is partly mediated by suppressing Her-2 activation.
  • Cx32 may serve as a potential therapeutic target for RCC.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...